Skip to main content

Research Repository

Advanced Search

Acceptability and engagement amongst patients on oral and intravenous bisphosphonates for the treatment of osteoporosis in older adults

Narayanasamy, Melanie; Bishop, Simon; Sahota, Opinder; Paskins, Zoe; Gittoes, Neil; Langley, Tessa

Acceptability and engagement amongst patients on oral and intravenous bisphosphonates for the treatment of osteoporosis in older adults Thumbnail


Authors

Opinder Sahota

Zoe Paskins

Neil Gittoes



Abstract

Background: Osteoporosis is common in older adults leading to fragility fractures at enormous individual and economic cost. Improving long-term adherence with bisphosphonate treatments reduces fracture risk, but adherence rates for first line oral bisphosphonate alendronate remains low. While alternative treatment regimens, including annual intravenous infusions are available, patient acceptability remains unclear. Therefore, understanding patients' acceptability and engagement in different bisphosphonate regimens is important to ensure optimal treatment benefits.
Methods: Semi-structured interviews were conducted with 78 patients with a mean age of 69.9 years, who had taken or received bisphosphonates for osteoporosis within the last 24 months. Data analysis included iterative categorization and used the Theoretical Framework of Acceptability (TFA) to compare the acceptability of
treatments regimens.
Results: Treatment acceptability and engagement were influenced by the extent to which patients understood the prescribed treatment, and evidence of the treatment working. Acceptability and engagement were compromised when treatment was perceived as burdensome, personal costs were incurred, and patients’ values were
incompatible with the regimen. The balancing of these factors contributed to patients’ ability to cope with the treatment and their emotional responses. Intravenous treatment was generally perceived as easier to understand, more effective, less burdensome with fewer opportunity costs, and a preferable regimen compared with oral bisphosphonates.
Conclusions: Annual intravenous zoledronate bisphosphonate treatment was generally more acceptable to patients, perceived as more straightforward to engage in, although a small portion of patients on oral bisphosphonates were satisfied with treatment. Further research is needed to identify how acceptability and engagement can be optimised.

Citation

Narayanasamy, M., Bishop, S., Sahota, O., Paskins, Z., Gittoes, N., & Langley, T. (2022). Acceptability and engagement amongst patients on oral and intravenous bisphosphonates for the treatment of osteoporosis in older adults. Age and Ageing, 51(11), Article afac255. https://doi.org/10.1093/ageing/afac255

Journal Article Type Article
Acceptance Date Sep 12, 2022
Online Publication Date Nov 20, 2022
Publication Date 2022-11
Deposit Date Sep 20, 2022
Publicly Available Date Nov 21, 2023
Journal Age and Ageing
Print ISSN 0002-0729
Electronic ISSN 1468-2834
Peer Reviewed Peer Reviewed
Volume 51
Issue 11
Article Number afac255
DOI https://doi.org/10.1093/ageing/afac255
Public URL https://nottingham-repository.worktribe.com/output/11465352
Publisher URL https://academic.oup.com/ageing/article-abstract/51/11/afac255/6834153
Additional Information This is a pre-copyedited, author-produced version of an article accepted for publication in Age and Ageing following peer review. The version of record Melanie Narayanasamy, Simon Bishop, Opinder Sahota, Zoe Paskins, Neil Gittoes, Tessa Langley, Acceptability and engagement amongst patients on oral and intravenous bisphosphonates for the treatment of osteoporosis in older adults, Age and Ageing, Volume 51, Issue 11, November 2022, afac255 is available online at: https://doi.org/10.1093/ageing/afac255